Total planned funding: $958,609,820
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $175,838,433 |
Ethiopia | $115,047,908 |
Zambia | $76,544,595 |
South Africa | $64,114,242 |
Uganda | $63,014,299 |
Mozambique | $59,928,332 |
Malawi | $34,069,032 |
Nigeria | $33,788,010 |
Tanzania | $30,981,124 |
India | $28,444,910 |
Rwanda | $27,302,722 |
Democratic Republic of the Congo | $22,716,840 |
Lesotho | $21,342,452 |
Zimbabwe | $21,279,946 |
Cambodia | $20,309,689 |
Ghana | $15,654,300 |
Russia | $15,588,568 |
Indonesia | $15,347,000 |
Dominican Republic | $15,215,315 |
Botswana | $13,828,645 |
Eswatini | $13,749,253 |
South Sudan | $12,478,087 |
Côte d'Ivoire | $9,774,677 |
Haiti | $9,622,000 |
China | $9,036,400 |
Ukraine | $7,848,152 |
Vietnam | $6,873,722 |
Thailand | $6,681,648 |
Angola | $5,470,000 |
Namibia | $4,219,519 |
Guyana | $2,500,000 |
Program Areas
Prevention | $247,210,585 |
Treatment | $236,387,816 |
Care | $226,351,979 |
Governance and Systems | $153,505,017 |
Testing | $64,697,575 |
Budget Codes
HTXD: Treatment: ARV Drugs | $137,003,746 |
HVOP: Sexual Prevention: Other Sexual Prevention | $115,771,471 |
HKID: Care: Orphans and Vulnerable Children | $101,267,668 |
HBHC: Care: Adult Care and Support | $95,183,447 |
HTXS: Treatment: Adult Treatment | $90,421,670 |
OHSS: Health Systems Strengthening | $81,923,163 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $65,503,900 |
HVCT: Testing: HIV Testing and Counseling | $64,697,575 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $49,470,224 |
HVSI: Strategic Information | $45,684,986 |
HLAB: Laboratory Infrastructure | $25,896,868 |
HVTB: Care: TB/HIV | $23,715,447 |
PDTX: Treatment: Pediatric Treatment | $8,962,400 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,403,655 |
PDCS: Care: Pediatric Care and Support | $6,185,417 |
HMIN: Biomedical Prevention: Injection Safety | $4,218,500 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,810,000 |
HMBL: Biomedical Prevention: Blood Safety | $2,032,835 |